Recent Updates
Recently added Catalysts
SRPT

Sarepta Therapeutics to Present at Upcoming Investor Conferences

Key Takeaway: CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences: Cowen

Full Press Release Details

CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:
Cowen 41st Annual Health Care Conference on Wednesday, Mar. 3, 2021 at 2:40 p.m. E.T.
Barclays Global Healthcare Conference on Wednesday, Mar. 10, 2021 at 2:25 p.m. E.T.
The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Internet Posting of Information
We routinely post information that may be important to investors in the ‘For Investors’ section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
Source: Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052, iestepan@sarepta.com
Tracy Sorrentino, 617-301-8566, tsorrentino@sarepta.com
Last updated: Feb 24, 2021